Figure 2.
Mean (±s.d.) rifabutin steady state plasma concentration-time profile following administration of rifabutin 300 mg once daily (Treatment A, •) or rifabutin 300 mg once daily plus SQV-SGC 1200 mg three times daily (Treatment C, ▪).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.